

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | The AAA superfamily (ATPases associated with diverse cellular activities) has been linked to a wide range of cellular processes, including cell division, cytoskeleton organization, and organelle biogenesis. Spastin is a microtubule-severing AAA protein needed for cell division and intracellular vesicle transport. Chemical probes that inhibit their activities in cells on similarly fast timescales can be valuable tools to dissect dynamic mechanisms. Spastazoline is a potent and selective cell-permeable probe for spastin with an IC50 of 99 ± 18 nM for human spastin. Treating HeLa-WT cells with spastazoline for 4.5 hours (10 µM) resulted in a ~2-fold increase in the number of cells with intercellular bridges compared to DMSO control indicating that spastazoline inhibits intercellular bridge disassembly by interfering with spastin activity. In dividing HeLa-WT cells treated with Spastazoline, EGFP-spastin accumulated at chromatin within 2–4 min after cleavage furrow ingression initiation. Imaging HeLa-WT cells in anaphase treated with spastazoline (10 µM for 1 hour) also revealed GFP-spastin puncta on chromosomes[1]. |
| Concentration | Treated Time | Description | References | |
| HeLa cells | 10 µM | 1 hour | To investigate the effect of Spastazoline on nuclear envelope reformation, results showed that Spastazoline treatment prolonged the persistence of GFP-spastin puncta on chromosomes. | Nat Chem Biol. 2019 May;15(5):444-452 |
| HeLa cells | 10 µM | 4.5 hours | To investigate the effect of Spastazoline on intercellular bridge disassembly, results showed that Spastazoline treatment increased the number of intercellular bridges in HeLa-WT cells but had no significant effect in HeLa-N386C cells. | Nat Chem Biol. 2019 May;15(5):444-452 |
| NGN2 neurons | 1 µM | 7 hours | To evaluate the inhibitory effect of Spastazoline on the microtubule-severing enzyme spastin and its impact on neuronal morphology in NGN2 neurons. Results showed that Spastazoline treatment did not significantly alter neurite arborization length (p=0.33 vs. control) but reduced Tubb3 signal intensity. | Mol Biol Cell. 2025 Jan 1;36(1):mr1 |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Contusion and lateral hemisection models of spinal cord injury | Intraperitoneal injection | 20 mg/kg | Immediately after SCI then every other day until the end of experiments | Spastazoline successfully reverses the FC-A-mediated locomotor recovery and nerve regeneration phenomena | Elife. 2024 Jan 17;12:RP90184 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.61mL 0.52mL 0.26mL |
13.07mL 2.61mL 1.31mL |
26.14mL 5.23mL 2.61mL |
|
| CAS号 | 2351882-11-4 |
| 分子式 | C20H30N8 |
| 分子量 | 382.51 |
| SMILES Code | CC(C)(C)C1=CC(NC2=C3C=CNC3=NC(N4CCN[C@H](C(C)C)C4)=N2)=NN1 |
| MDL No. | MFCD31813810 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | HNOLTAKAPDKZRY-AWEZNQCLSA-N |
| Pubchem ID | 135397891 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(274.51 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1